Product Information
VYTORIN 10-20 MG TABLET is a brand product labeled by Organon LLC, priced at $13.6206 per EA under NDC 78206017502. Its NADAC has been published 129 times since Apr 17, 2024.
FDA first approved this application on Jul 23, 2004. Its Orange Book therapeutic-equivalence code is AB — FDA rates it therapeutically equivalent to (substitutable for) its reference product.
The High Outlier badge above means this manufacturer's average price in the ezetimibe and simvastatin market falls above Q3 + 1.5·IQR across all competing manufacturers. We only apply this flag in markets with four or more competitors. Full definition: glossary → outlier.
Strength
10; 20 mg/1; mg/1
Manufacturer
Organon LLCNDC
78206017502
Classification
Brand
Dosage Form
TABLET
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
EZETIMIBE; SIMVASTATINApproval Type
New Drug (NDA)
FDA Application
NDA021687FDA Approved
7/23/2004
TE Code
AB
On Market Since
6/1/2021
Pharmacological Classes
Price Statistics
The NADAC for VYTORIN 10-20 MG TABLET has been published 129 times since Apr 17, 2024, and over the history we have for it it has risen 8.7%. The table below summarizes its recorded NADAC range and movement.
| Current price | $13.6206 per EA |
|---|---|
| All-time high | $13.8891 (Aug 12, 2026) |
| All-time low | $12.5269 (Apr 17, 2024) |
| 52-week high | $13.8891 |
| 52-week low | $13.2279 |
| Median price | $13.2126 |
| Average price | $13.2200 |
| Largest weekly change | +5.0% (Jan 1, 2025) |
| Weeks tracked | 129 |
| Tracking since | Apr 17, 2024 |
Generic Alternatives
The matcher finds 3 manufacturers offering a NADAC-published product with this drug's active ingredient and strength in a comparable dosage form (cheapest from each manufacturer, up to 10 shown below). Switching to the cheapest would cut per-unit acquisition cost by roughly 99% at current NADAC. These are candidates to verify clinically, not guaranteed substitutes — see our generic drug prices guide.
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Organon LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
ezetimibe and simvastatin market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Dietary Cholesterol Absorption Inhibitor class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of VYTORIN 10-20 MG TABLET?
The current National Average Drug Acquisition Cost (NADAC) for VYTORIN 10-20 MG TABLET, manufactured by Organon LLC, is $13.6206 per EA (NDC 78206017502), effective Sep 30, 2026.
How has the price of VYTORIN 10-20 MG TABLET changed over time?
Over the history we have for it, the NADAC for VYTORIN 10-20 MG TABLET has risen 8.7%. It has been tracked across 129 weekly CMS publications since Apr 17, 2024.
What are the highest and lowest recorded NADAC prices for VYTORIN 10-20 MG TABLET?
Since Apr 17, 2024, the NADAC for VYTORIN 10-20 MG TABLET has ranged from a low of $12.5269 (Apr 17, 2024) to a high of $13.8891 (Aug 12, 2026), with a median of $13.2126 per EA.
Are there cheaper alternatives to VYTORIN 10-20 MG TABLET?
Yes. 3 manufacturers publish a NADAC-priced product with the same active ingredient and strength in a comparable dosage form. The lowest-priced option, EZETIMIBE-SIMVASTATIN 10-20 MG, is $0.1985 per EA — about 99% below VYTORIN 10-20 MG TABLET.
Who manufactures VYTORIN 10-20 MG TABLET?
VYTORIN 10-20 MG TABLET (NDC 78206017502) is labeled by Organon LLC, and CMS classifies it as a brand product.